drug testing

Our Organoid Lab provides a platform to test FDA-approved drugs on PDO for personalised therapy, and small-molecules chemical screen of new compounds. 

Patient-derived colorectal cancer (CRC) organoid

Sensitivity to MEK inhibitor Trametinib    

Resistance to mTOR inhibitor (Everolimus) and PI3K inhibitor (Alpelisib)